Recital 1, Decision_act (EU) 2025/1813

In forcesince 11 Sep 2025

On 30 June 2017, VEOLIA WATER SOLUTIONS & TECHNOLOGIES SUPPORT (the ‘applicant’) submitted an application to the European Chemicals Agency (‘the Agency’) in accordance with Article 43(1) of Regulation (EU) No 528/2012 and Article 4 of Commission Implementing Regulation (EU) No 414/2013 [Commission Implementing Regulation (EU) No 414/2013 of 6 May 2013 specifying a procedure for the authorisation of same biocidal products in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 125, 7.5.2013, p. 4, ELI: http://data.europa.eu/eli/reg_impl/2013/414/oj).] for Union authorisation of the same biocidal product family, as referred to in Article 1 of Implementing Regulation (EU) No 414/2013. That biocidal product family was named ‘VEOLIA WATER TECHNOLOGIES CMIT/MIT biocidal product family’, of product-types 6, 11, 12 and 13, as described in Annex V to Regulation (EU) No 528/2012. The application was recorded under case number BC-MG032941-44 in the Register for Biocidal Products. The application also indicated the case number of the related reference product family ‘LANXESS CMIT/MIT biocidal product family’, later authorised by Commission Implementing Regulation (EU) 2024/2750 [Commission Implementing Regulation (EU) 2024/2750 of 25 October 2024 granting a Union authorisation for the biocidal product family ‘LANXESS CMIT/MIT biocidal product family’ in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L, 2024/2750, 28.10.2024, ELI: http://data.europa.eu/eli/reg_impl/2024/2750/oj).], with authorisation number EU-0031652-0000.